๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Significance of mediastinal metastatic disease in Wilms' tumor of favorable histology

โœ Scribed by Cushing, Barbara A. ;Watts, Frederick B. ;Brough, A. Joseph ;Philippart, Arvin I. ;Das, Lakshmi


Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
316 KB
Volume
12
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

โœฆ Synopsis


Although the results of the National Wilms' Tumor Study suggest poor outcome for children with metastases to intra-abdominal, intracranial, skeletal, skin, diaphragm, or mediastinal sites, the incidence and course of mediastinal disease has not been described. Fifty-four newly diagnosed Wilms' tumor patients at Children's Hospital of Michigan (1972-1980) were studied for patterns of intrathoracic metastases. All had favorable histology; mean age (MA) at diagnosis was 4.5 years. Initial chemotherapy ranged from single agent to three-drug combination (actinomycin, vincristine, adriamycin). Intrathoracic metastases occurred in 14 (26%) from 0-28 months (median, 3.5 months) from diagnosis (MA, 5.8 years). Upon the discovery of intrathoracic metastases all received radiation (1,200-2,000 rads) to the chest, some with supplementary doses to the mediastinum. Five children with parenchymal and one with parenchymal and hilar metastases appearing 0-28 months after the time of diagnosis survive disease-free 44-127 months after metastases appeared (MA, 6.3 years). Eight children developed parenchymal and mediastinal metastases (MA, 5.4 years). Time from diagnosis to parenchymal metastases was 0-7 months; time from diagnosis to mediastinal metastases was 0-16 months; and in four, both sites appeared simultaneously. Death occurred in all eight patients 7-25 months from diagnosis. Only one child had evidence of recurrence outside the chest. Potential risk factors and influence on survival are discussed.


๐Ÿ“œ SIMILAR VOLUMES


Treatment of children with stage IV favo
โœ Green, Daniel M.; Breslow, Norman E.; Evans, Ilonka; Moksness, Jami; D'Angio, Gi ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 491 KB ๐Ÿ‘ 2 views

The purpose of this study was to evaluate the effect of the sequential addition of doxorubicin and cyclophosphamide to the combination of vincristine and actinomycin D o n the relapse-free survival of children with stage IV/favorable histology Wilms tumor. We reviewed the clinical courses of all ran

Prognostic classification of relapsing f
โœ Richard D Williams; Sandra N. Hing; Braden T. Greer; Craig C. Whiteford; Jun S. ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 575 KB

Treatment of Wilms tumor has a high success rate, with some 85% of patients achieving long-term survival. However, late effects of treatment and management of relapse remain significant clinical problems. If accurate prognostic methods were available, effective risk-adapted therapies could be tailor

Radiotherapy omitted in the treatment of
โœ Pachnis, A.; Pritchard, J.; Gaze, M.; Levitt, G.; Michalski, A. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 54 KB ๐Ÿ‘ 3 views

Background. Current treatment of stage III favorable histology (FH) Wilms tumor is surgery, radiotherapy to residual disease, and ''triple'' chemotherapy (vincristine, dactinomycin, and doxorubicin) for 12 months. This study tests the hypothesis that some stage III patients, especially very young ch